Document ID: chunk:federal_register_of_legislation:F2024C00531:reg:10:p2
Version: federal_register_of_legislation:F2024C00531
Segment Type: reg
Provision Reference: reg 10 (pt 2/3)
Character Range: 19834–23807

clause(s)                                   par = paragraph(s)/subparagraph(s)
C[x] = Compilation No. x                        /sub‑subparagraph(s)
Ch = Chapter(s)                                 pres = present
def = definition(s)                             prev = previous
Dict = Dictionary                               (prev…) = previously
disallowed = disallowed by Parliament           Pt = Part(s)
Div = Division(s)                               r = regulation(s)/rule(s)
ed = editorial change                           reloc = relocated
exp = expires/expired or ceases/ceased to have  renum = renumbered
effect                                          rep = repealed
F = Federal Register of Legislation             rs = repealed and substituted
gaz = gazette                                   s = section(s)/subsection(s)
LA = Legislation Act 2003                       Sch = Schedule(s)
LIA = Legislative Instruments Act 2003          Sdiv = Subdivision(s)
(md) = misdescribed amendment can be given      SLI = Select Legislative Instrument
effect                                          SR = Statutory Rules
(md not incorp) = misdescribed amendment        Sub‑Ch = Sub‑Chapter(s)
cannot be given effect                          SubPt = Subpart(s)
mod = modified/modification                     underlining = whole or part not
No. = Number(s)                                 commenced or to be commenced

Endnote 3—Legislation history

Name                                                                            Registration                Commencement                                       Application, saving and transitional provisions
Therapeutic Goods (Charges) Regulations 2018                                    14 June 2018 (F2018L00774)  s 5–9 and Sch 1: 1 July 2018 (s 2(1) item 2)
                                                                                                            Remainder: 15 June 2018 (s 2(1) item 1)
Therapeutic Goods (Charges) Amendment Regulations 2019                          25 Mar 2019 (F2019L00395)   1 July 2019 (s 2(1) item 1)                        —
Therapeutic Goods Legislation Amendment (2019 Measures No. 1) Regulations 2019  18 Dec 2019 (F2019L01660)   Sch 1 (items 44, 45): 25 Nov 2021 (s 2(1) item 2)  —
as amended by
Therapeutic Goods Legislation Amendment (2020 Measures No. 1) Regulations 2020  23 July 2020 (F2020L00946)  Sch 8 (item 1): 24 July 2020 (s 2(1) item 7)       —
Therapeutic Goods (Charges) Amendment (2020 Measures No. 1) Regulations 2020    16 June 2020 (F2020L00727)  1 July 2020 (s 2(1) item 1)                        —
Therapeutic Goods (Charges) Amendment (2021 Measures No. 1) Regulations 2021    4 June 2021 (F2021L00694)   1 July 2021 (s 2(1) item 1)                        —
Therapeutic Goods (Charges) Amendment (2022 Measures No. 1) Regulations 2022    11 Apr 2022 (F2022L00589)   1 July 2022 (s 2(1) item 1)                        —
Therapeutic Goods (Charges) Amendment (2023 Measures No. 1) Regulations 2023    9 June 2023 (F2023L00758)   1 July 2023 (s 2(1) item 1)                        —
Therapeutic Goods (Charges) Amendment (2024 Measures No. 1) Regulations 2024    17 June 2024 (F2024L00688)  1 July 2024 (s 2(1) item 1)                        —

Endnote 4—Amendment history

Provision affected          How affected
Part 1
s 2.....................    rep LA s 48D
s 4.....................    rep LA s 48C
Part 2
s 7.....................    am F2019L00395; F2019L01660; F2020L00727; F2021L00694; F2022L00589; F2023L00758
                            ed C6
                            am F2024L00688
s 8.....................    am F2019L00395; F2020L00727; F2021L00694; F2022L00589; F2023L00758; F2024L00688
s 9.....................    am F2019L00395; F2020L00727; F2021L00694; F2022L00589; F2023L00758; F2024L00688
Part 3
Part 3...................   ad F2019L01660
Division 1
s 10....................    ad F2019L01660
Schedule 1................  rep LA s 48C